Ankylosing Spondylitis Bulk Plasma
Ankylosing Spondylitis Bulk Plasma is collected via apheresis using Acid-Citrate-Dextrose Formula A (ACDA). Tested negative for HIV, HBV, and HCV, and ideal for immunology, biomarker discovery, and disease-specific assay development.
Ankylosing Spondylitis Bulk Plasma Collected via Apheresis in ACDA
Ankylosing Spondylitis Plasma is collected from IRB-consented donors diagnosed with Ankylosing Spondylitis, using apheresis and ACDA (Acid-Citrate-Dextrose Formula A) as the anticoagulant. This disease-state plasma supports immunological and biomarker research and is ideal for assay development and therapeutic discovery.
Product Features
- High-volume plasma collected via apheresis
- Anticoagulated using ACDA
- Tested and confirmed negative for HIV, HBV, and HCV
- Available fresh with custom volumes upon request
- IRB-approved informed consent and HIPAA-compliant handling
De-identified Donor Data
- Clinically confirmed diagnosis of Ankylosing Spondylitis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Clinical history and medication data available
Applications
- Disease-specific biomarker discovery
- Inflammatory and immunological assay development
- Proteomic, metabolomic, and cytokine profiling
- Therapeutic development and validation studies
Compliance and Quality Assurance
- Screened negative for HIV, HBV, and HCV
- IRB-approved collection with 21 CFR Part 11–compliant consent
- Standardized processing and cryopreservation protocols
Ordering & Customization
Ankylosing Spondylitis Bulk Plasma is available in standard or custom volumes. For documentation or international shipping, please contact learnmore@sanguinebio.com.
Frequently Asked Questions
Ask a Question
Need a custom Bulk Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.